doi:10.3969/j.issn.1673-8640.2019.12.020

Abstract

CLC Number:

R446.1

References 14

[1]	贾晓玉,刘丽萍,崔昭,等. 血浆置换治疗清除抗肾小球基底膜抗体的效率及其与肾脏预后的关系[J]. 中国血液净化,2018,17(10):672-676.
[2]	崔昭,贾晓玉,刘畅,等. 识别不同靶抗原的抗肾小球基底膜抗体与临床表型相关[J]. 中国血液净化,2010,9(3):147-151.
[3]	牟利军,陈丽萌,左来孟,等. 抗肾小球基底膜病临床病理及血浆置换疗效分析[J]. 中华肾脏病杂志,2011,27(4):230-235.
[4]	LAHMER T,HEEMANN U.Anti-glomerular basement membrane antibody disease:a rare autoimmune disorder affecting the kidney and the lung[J]. Autoimmun Rev,2012,12(2):169-173.
[5]	CUI Z,ZHAO M H,JIA X Y,et al.Antibodies to α5 chain of collagen Ⅳ are pathogenic in Goodpasture's disease[J]. J Autoimmun,2016,70:1-11.
[6]	崔昭,赵明辉,辛岗,等. 肾功能正常的抗肾小球基膜抗体相关疾病——附3例报道[J]. 肾脏病与透析肾移植杂志,2003,12(3):211-214.
[7]	刘伟. 肾功能正常的抗肾小球基底膜病临床分析[J]. 中国煤炭工业医学杂志,2014,17(10):1594-1596.
[8]	郭亚平,王春光,刘欣,等. 健康体检人群不同性别抗核抗体随年龄分布规律探讨[J]. 中华微生物学和免疫学杂志,2014,34(3):212-215.
[9]	郭亚平,王春光,刘欣,等. 抗线粒体抗体-M2阳性体检人群原发性胆汁性肝硬化相关指标的调查分析[J]. 中华肝脏病杂志,2014,22(10):735-738.
[10]	郭亚平,刘欣,周强,等. 抗线粒体抗体-M2阳性人群相关实验室检测异常指标分析[J]. 中国卫生检验杂志,2016,26(23):3418-3419.
[11]	郭亚平,王春光,刘欣,等. 抗线粒体抗体-M2阳性体检人群与原发性胆汁性肝硬化患者相关临床特征横断面比较[J]. 中西医结合肝病杂志,2015,25(6):356-359.
[12]	郭亚平,王春光,刘欣,等. 健康体检人群与临床就诊人群抗核抗体谱分布状况对比分析[J]. 中华健康管理学杂志,2013,7(4):281-284.
[13]	崔昭,赵明辉. 抗肾小球基底膜病及其免疫发病机制的研究进展[J]. 郑州大学学报(医学版),2008,43(1):10-13.
[14]	CUI Z,ZHAO M H.Avidity of anti-glomerular basement menbrane autoantibodies was associated with disease severity[J]. Clin Immunol,2005,116(1):77-82.

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 14

Related Articles 15

Recommended Articles

Metrics